Gabriel S. Morris, CFO at Immix Biopharma, Inc. (IMMX), bought 5,200 shares at $0.94 ($5K) on 2022-11-14, disclosed to the SEC on 2022-11-15.
Open-market purchase of $5k IMMX by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| IMMX | BUY | 2025-06-20 | $5K | — | Filing → |
| IMMX | BUY | 2024-06-10 | $5K | — | Filing → |
| IMMX | BUY | 2024-06-05 | $6K | — | Filing → |